35.21 USD
-0.33 (-0.93%)
35.21 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to INDV. INDV was compared to 192 industry peers in the Pharmaceuticals industry. INDV has an excellent profitability rating, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on INDV.
1. Profitability
1.1 Basic Checks
INDV had positive earnings in the past year.
INDV had a positive operating cash flow in the past year.
In multiple years INDV reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: INDV reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of 8.62%, INDV belongs to the top of the industry, outperforming 90.10% of the companies in the same industry.
The Return On Invested Capital of INDV (50.62%) is better than 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for INDV is significantly above the industry average of 12.85%.
The last Return On Invested Capital (50.62%) for INDV is above the 3 year average (43.06%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.62% | ||
| ROE | N/A | ||
| ROIC | 50.62% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
1.3 Margins
INDV has a better Profit Margin (10.34%) than 83.85% of its industry peers.
INDV's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 24.49%, INDV belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
INDV's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 85.51%, INDV belongs to the best of the industry, outperforming 88.54% of the companies in the same industry.
INDV's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.49% | ||
| PM (TTM) | 10.34% | ||
| GM | 85.51% |
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
2. Health
2.1 Basic Checks
INDV has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
INDV has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, INDV has less shares outstanding
The debt/assets ratio for INDV is higher compared to a year ago.
2.2 Solvency
INDV has an Altman-Z score of 2.75. This is not the best score and indicates that INDV is in the grey zone with still only limited risk for bankruptcy at the moment.
INDV has a Altman-Z score of 2.75. This is in the better half of the industry: INDV outperforms 64.06% of its industry peers.
INDV has a debt to FCF ratio of 2.68. This is a good value and a sign of high solvency as INDV would need 2.68 years to pay back of all of its debts.
The Debt to FCF ratio of INDV (2.68) is better than 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.68 | ||
| Altman-Z | 2.75 |
ROIC/WACC5.39
WACC9.39%
2.3 Liquidity
A Current Ratio of 0.96 indicates that INDV may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.96, INDV is doing worse than 85.94% of the companies in the same industry.
A Quick Ratio of 0.79 indicates that INDV may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.79, INDV is doing worse than 82.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 239.13% over the past year.
The earnings per share for INDV have been decreasing by -53.19% on average. This is quite bad
The Revenue has decreased by -0.25% in the past year.
INDV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.64% yearly.
EPS 1Y (TTM)239.13%
EPS 3Y-75.32%
EPS 5Y-53.19%
EPS Q2Q%94.12%
Revenue 1Y (TTM)-0.25%
Revenue growth 3Y14.52%
Revenue growth 5Y8.64%
Sales Q2Q%2.28%
3.2 Future
Based on estimates for the next years, INDV will show a very strong growth in Earnings Per Share. The EPS will grow by 54.72% on average per year.
Based on estimates for the next years, INDV will show a small growth in Revenue. The Revenue will grow by 1.36% on average per year.
EPS Next Y832.8%
EPS Next 2Y229.55%
EPS Next 3Y125.91%
EPS Next 5Y54.72%
Revenue Next Year2.47%
Revenue Next 2Y-1.5%
Revenue Next 3Y0.11%
Revenue Next 5Y1.36%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 17.96, which indicates a rather expensive current valuation of INDV.
Compared to the rest of the industry, the Price/Earnings ratio of INDV indicates a rather cheap valuation: INDV is cheaper than 83.85% of the companies listed in the same industry.
INDV is valuated rather cheaply when we compare the Price/Earnings ratio to 26.39, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 12.57 indicates a correct valuation of INDV.
INDV's Price/Forward Earnings ratio is rather cheap when compared to the industry. INDV is cheaper than 84.38% of the companies in the same industry.
INDV's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.84.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.96 | ||
| Fwd PE | 12.57 |
4.2 Price Multiples
82.81% of the companies in the same industry are more expensive than INDV, based on the Enterprise Value to EBITDA ratio.
INDV's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. INDV is cheaper than 79.69% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.63 | ||
| EV/EBITDA | 13.56 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of INDV may justify a higher PE ratio.
A more expensive valuation may be justified as INDV's earnings are expected to grow with 125.91% in the coming years.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y229.55%
EPS Next 3Y125.91%
5. Dividend
5.1 Amount
No dividends for INDV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
35.21
-0.33 (-0.93%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners93.08%
Inst Owner Change240.03%
Ins Owners3.78%
Ins Owner ChangeN/A
Market Cap4.40B
Revenue(TTM)1.18B
Net Income(TTM)122.00M
Analysts84.62
Price Target38.61 (9.66%)
Short Float %4.77%
Short Ratio2.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)81.89%
Min EPS beat(2)71.47%
Max EPS beat(2)92.31%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)19.31%
Min Revenue beat(2)17.53%
Max Revenue beat(2)21.1%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)159.52%
PT rev (3m)159.52%
EPS NQ rev (1m)6.31%
EPS NQ rev (3m)N/A
EPS NY rev (1m)75.01%
EPS NY rev (3m)76.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)11.51%
Revenue NY rev (3m)12.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.96 | ||
| Fwd PE | 12.57 | ||
| P/S | 3.73 | ||
| P/FCF | 36.63 | ||
| P/OCF | 24.42 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.56 |
EPS(TTM)1.96
EY5.57%
EPS(NY)2.8
Fwd EY7.96%
FCF(TTM)0.96
FCFY2.73%
OCF(TTM)1.44
OCFY4.09%
SpS9.45
BVpS-1.66
TBVpS-1.67
PEG (NY)0.02
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.62% | ||
| ROE | N/A | ||
| ROCE | 64.08% | ||
| ROIC | 50.62% | ||
| ROICexc | 3805.17% | ||
| ROICexgc | 5707.75% | ||
| OM | 24.49% | ||
| PM (TTM) | 10.34% | ||
| GM | 85.51% | ||
| FCFM | 10.17% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)54.5%
ROCE(5y)38.6%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
F-Score8
Asset Turnover0.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.68 | ||
| Debt/EBITDA | 0.97 | ||
| Cap/Depr | 230.77% | ||
| Cap/Sales | 5.08% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 57.14% | ||
| Profit Quality | 98.36% | ||
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 2.75 |
F-Score8
WACC9.39%
ROIC/WACC5.39
Cap/Depr(3y)163.83%
Cap/Depr(5y)132.28%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)239.13%
EPS 3Y-75.32%
EPS 5Y-53.19%
EPS Q2Q%94.12%
EPS Next Y832.8%
EPS Next 2Y229.55%
EPS Next 3Y125.91%
EPS Next 5Y54.72%
Revenue 1Y (TTM)-0.25%
Revenue growth 3Y14.52%
Revenue growth 5Y8.64%
Sales Q2Q%2.28%
Revenue Next Year2.47%
Revenue Next 2Y-1.5%
Revenue Next 3Y0.11%
Revenue Next 5Y1.36%
EBIT growth 1Y8.24%
EBIT growth 3Y11.69%
EBIT growth 5Y7.28%
EBIT Next Year1034.05%
EBIT Next 3Y143.47%
EBIT Next 5Y64.69%
FCF growth 1Y236.36%
FCF growth 3Y-74.97%
FCF growth 5Y-48.94%
OCF growth 1Y446.15%
OCF growth 3Y-53.28%
OCF growth 5Y-24.93%
INDIVIOR PLC / INDV FAQ
What is the fundamental rating for INDV stock?
ChartMill assigns a fundamental rating of 5 / 10 to INDV.
Can you provide the valuation status for INDIVIOR PLC?
ChartMill assigns a valuation rating of 7 / 10 to INDIVIOR PLC (INDV). This can be considered as Undervalued.
What is the profitability of INDV stock?
INDIVIOR PLC (INDV) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for INDV stock?
The Price/Earnings (PE) ratio for INDIVIOR PLC (INDV) is 17.96 and the Price/Book (PB) ratio is -21.24.
What is the financial health of INDIVIOR PLC (INDV) stock?
The financial health rating of INDIVIOR PLC (INDV) is 4 / 10.